Cabergoline is available in tab form and is taken orally. It is prescribed based on medical condition being treated.

Hyperprolactinemia: Generally, treatment begins at a minimal dose. Most common is 0.25 mg twice a week, with gradual increase as tolerated by the patient and the response is also taken into account. Generally, the highest dose accepted is 1 mg twice a week; however, dosages may be adjusted as appropriate to the clinical condition of the patient.

For Parkinson’s disease: Cabergoline is typically given as an adjunct to other therapies and dosing is started low and gradually increased. Dosage will depend on the patient.

Cabergoline must be taken exactly as prescribed by a doctor. Missing doses or stopping the medication can cause symptoms to return and withdrawal should not be abrupt.

Cabergoline works majorly through the stimulation of dopamine D2 receptors distributed across all parts of the brain including the pituitary. Cabergoline works on such receptors in the pituitary to inhibit prolactin release.

Prolactin is a hormone involved in milk production, and its levels are usually tightly regulated by dopamine. In conditions where the pituitary gland secretes excess prolactin, cabergoline works by restoring normal dopamine regulation, reducing prolactin secretion.

Cabergoline is generally well tolerated but may cause side effects, some of which are serious. Common and less serious side effects include

Nausea and vomiting: Some patients will have gastrointestinal upset, mainly at the beginning of the treatment.

Dizziness or lightheadedness: This is possible, especially when changing from a lying to a sitting or standing position, because it lowers blood pressure.

Headache: This is one of the most common side effects that may appear during the treatment.

Fatigue or drowsiness: Some patients feel unusually tired or drowsy.

Constipation: Cabergoline slows down bowel movements in some patients

Cardiovascular monitoring: Patients on cabergoline should be monitored for cardiovascular symptoms, especially if they have a history of heart disease. The drug can cause changes in blood pressure and has been associated with heart valve problems, especially when used for long periods at high doses.

Pregnancy and breastfeeding: Cabergoline should be administered to pregnant women only if the benefits have outweighed the risks, as it is classified among Category B drugs; no effects have been shown in animals. Cabergoline does not have any use by breastfeeding mothers since it inhibits milk production.

Psychiatry side effects: Monitoring of patients with a medical history of mental illness conditions for changes in mood, behavior patterns, or signs of psychosis.

Caution in renal impairment: Although cabergoline is metabolized in the liver, caution should be taken in patients with severe kidney disease, as renal impairment may affect the elimination of the drug.

Abrupt discontinuation: Discontinuing cabergoline suddenly can lead to the recurrence of prolactin-related symptoms (e.g., menstrual irregularities or galactorrhea). It is important to follow a healthcare provider’s guidance when adjusting or stopping the medication.

1. Antipsychotics: Medications like haloperidol or other antipsychotics may reduce the effectiveness of cabergoline, as they block dopamine receptors. This could interfere with its ability to lower prolactin levels.
2. Dopamine Agonists: Co-administration with other dopamine agonists, such as bromocriptine, can increase the risk of side effects like dizziness, hypotension, and nausea due to cumulative dopaminergic effects.
3. Antihypertensive Drugs: Cabergoline may lower blood pressure, and when taken with antihypertensive medications, there is an increased risk of excessive hypotension, particularly when starting treatment.
4. Macrolide Antibiotics: Drugs like erythromycin, which inhibit cytochrome P450 enzymes, may increase cabergoline levels, raising the risk of side effects like nausea, vomiting, or dizziness.

These interactions highlight the importance of careful monitoring and potential dose adjustments when using cabergoline with other medications.

For hyperprolactinemia:

Initiation dose: 0.25 mg twice a week, administered with food to minimize gastrointestinal side effects.

Increase in dose: The dose should be titrated according to response and tolerability. The recommended dose range for most patients is 0.5 mg to 1 mg twice a week.

In most patients, the maximal recommended dose is 1 mg twice a week.

For PD:

Cabergoline is typically started at a low dose (e.g., 0.5 mg daily) and then increased slowly as needed.

The dose for Parkinson’s disease is typically higher than for hyperprolactinemia, but it varies based on individual patient needs.

Cabergoline is prescription only, so it would be prescribed based on the patient’s medical condition through a provider, especially if the reason for its use is hyperprolactinemia or Parkinson’s disease. Careful monitoring of the drug might be needed, including looking at prolactin, heart function, and overall mental status.

Health care providers will watch for indicators of cardiovascular diseases, especially when they are using cabergoline for a long time, as well as psychiatric and behavioral side effects of the drug.

1. What is Cabergoline?
   Cabergoline is a medication used to lower elevated levels of prolactin, primarily in conditions such as prolactinomas and other disorders of hyperprolactinemia.

2. How does Cabergoline work?
   Cabergoline functions as a dopamine agonist, which means it stimulates dopamine receptors in the brain to inhibit prolactin secretion from the pituitary gland.

3. What conditions is Cabergoline used to treat?
   Cabergoline is primarily used to treat acromegaly, Parkinson’s disease, and disorders associated with excessive prolactin levels, such as prolactinomas.

4. What is the usual dosage of Cabergoline?
   The typical starting dose is 0.5 mg twice weekly, which may be adjusted based on individual response and prolactin levels, but doses can vary among patients.

5. How is Cabergoline administered?
   Cabergoline is usually taken orally in tablet form, typically with or without food as directed by a healthcare provider.

6. What are the common side effects of Cabergoline?
   Common side effects include nausea, dizziness, headache, fatigue, and constipation. Some people may also experience low blood pressure.

7. Are there any serious side effects associated with Cabergoline?
   Serious side effects can include heart valve problems, severe allergic reactions, and mental health changes. Patients should seek medical attention if they experience chest pain or breathing issues.

8. Can Cabergoline be taken during pregnancy?
   Pregnancy status should be discussed with a healthcare provider. Cabergoline may not be recommended during pregnancy due to insufficient data on its safety.

9. What should I do if I miss a dose of Cabergoline?
   If you miss a dose, take it as soon as you remember unless it’s close to the next scheduled dose. In that case, skip the missed dose and continue with your regular dosing schedule.

10. Can Cabergoline interact with other medications?
    Yes, Cabergoline can interact with other medications, including antihypertensives, anti-nausea drugs, and other dopamine agonists. Always inform your doctor about all medications you are taking.

11. Is Cabergoline addictive?
    Cabergoline is not considered addictive, but patients should take it only as prescribed to avoid potential side effects.

12. Can Cabergoline affect fertility?
    Cabergoline may restore fertility in women with hyperprolactinemia; however, it’s essential to discuss any fertility concerns with a healthcare provider.

13. How is the effectiveness of Cabergoline monitored?
    Effectiveness is monitored through blood tests to measure prolactin levels and regular follow-ups with a healthcare provider.

14. What lifestyle changes can support Cabergoline treatment?
    Maintaining a balanced diet, regular exercise, and adhering to prescribed medication schedules can support treatment effectiveness.

15. Can Cabergoline cause weight gain?
    Some patients may experience weight changes while taking Cabergoline, but individual responses can vary. Monitoring weight and discussing changes with a doctor is advisable.

16. What precautions should I take while using Cabergoline?
    Patients should be cautious when driving or operating machinery until they know how Cabergoline affects them, as it can cause dizziness or drowsiness.

17. Are there any special storage instructions for Cabergoline?
    Cabergoline should be stored at room temperature, away from moisture and light, and out of reach of children.

18. What should I do if I experience severe side effects?
    If you experience severe side effects, such as chest pain, difficulty breathing, or severe headaches, seek immediate medical attention.

19. Is Cabergoline suitable for elderly patients?
    Elderly patients may be more sensitive to the effects of Cabergoline, so dosage adjustments and careful monitoring are typically recommended.

20. How can I learn more about my treatment with Cabergoline?
    For more information, consult your healthcare provider or pharmacist, who can provide personalized guidance and answer any specific questions you may have.